Dimerix Bioscience
Posted: September 6, 2015 at 9:45 pm
Developing and Commercialising Drug Therapies
Dimerix Bioscience is a public unlisted clinical stage drug discovery and development company, and a wholly owned subsidiary of Sun Biomedical Limited (ASX:SBN Sun Biomedical Home Page). Based in Melbourne, Dimerixs lead clinical program is a Phase 2 study in Chronic Kidney Disease, DMX-200. This study has repurposing of existing molecules at its core, and upon successful results from this study, Dimerix intends to pursue the pathway of registration of a product for an orphan indication. The study has been initiated at the Austin Hospital under the supervision of Professor Power, and is currently recruiting patients.
The therapeutic rationale for DMX-200 was developed from Dimerixs core patented technology, known as Receptor Heteromer Investigation Technology (Receptor HIT) which can be used to elucidate receptor interactions. Applying this technology to receptors such as G-protein coupled receptors (GPCRs), Dimerix is able to identify differences in signaling behavior when receptors interact as heteromers, as expected in vivo, compared with the traditional analysis of single target receptors in isolation. In recent years Dimerix has been approached by several top 10 Pharmaceutical companies, and has assisted these with their drug discovery programs by applying the HIT technology and in house knowledge. These studies have assisted in validating Dimerixs in vitro approach as a rationale for pursuing in vivo therapeutic studies.
Read more here:
Dimerix Bioscience
- BioOne Online Journals - BioScience - May 7th, 2016
- Alligator Bioscience AB - May 7th, 2016
- Seahorse Bioscience - Making Cell Metabolism Even Easier - May 7th, 2016
- Enzyme Bioscience Private Limited - October 25th, 2015
- Fumagillin Supplier | CAS 23110-15-8 | Tocris Bioscience - October 25th, 2015
- BioScience - September 28th, 2015
- Chinese Bioscience Association | CBA: Biotech, Life ... - September 20th, 2015
- Bioscience - Kansas Department of Commerce - September 16th, 2015
- Whitney Laboratory for Marine Bioscience - St. Augustine, FL - August 21st, 2015
- Amarantus Bioscience Holdings Inc. (AMBS ... - InvestorsHub - July 31st, 2015
- Aryu-Deva BioScience Renewal Complex - July 15th, 2015
- Bioscience Technology | Daily news and top headlines for ... - July 8th, 2015
- VIVO: Summary for Meridian Bioscience Inc.- Yahoo! Finance - May 31st, 2015
- Bioscience Horizons - May 5th, 2015